Propel Bio Partners L.P.
Propel Bio Partners L.P. is a private equity fund based in Los Angeles, California. According to its most recent Form D, filed Mar 15, 2023, it has sold $38,950,000 of interests to 14 investors since its first sale in May 2022. The filing does not set a minimum investment. It relies on the Section 3(c)(1) exclusion, which limits it to 100 beneficial owners, typically accredited investors. The offering uses Rule 506(b), which does not permit general solicitation. Related persons named in the filing include Leen Kawas; a Delaware Limited Liability Company PBP Partners LLC.
- Total raised
- $38,950,000Cumulative sales reported on Form D
- Investors
- 14
- First sale
- May 4, 2022
- Minimum investment
- None set
- Who can invest
- Accredited investorsSection 3(c)(1): up to 100 beneficial owners
- Offering exemption
- Rule 506(b)No general advertising
- Key people and entities
- Leen Kawas; a Delaware Limited Liability Company PBP Partners LLC
- Latest Form D
- Mar 15, 2023
From SEC filings, not verified. This page republishes the fund's Form D as filed. It is not an offer, solicitation or recommendation, and AltMountain has not reviewed the fund. “Raised” is cumulative sales, not current assets or performance. Returns are not part of SEC filings. Private funds are speculative, illiquid and generally limited to accredited investors or qualified purchasers. Full disclosures · Request a correction
Raise history
| Filed | Filing | Total raised | Investors | Source |
|---|---|---|---|---|
| Mar 15, 2023 | Form D/A (amendment) | $38,950,000 | 14 | SEC.gov ↗ |
| Mar 18, 2022 | Form D | $0 | 0 | SEC.gov ↗ |
2 Form D filings in the SEC's electronic records (2008 onward), the earliest on Mar 18, 2022. Each filing reports the cumulative amount sold and the number of investors to that date, as the fund filed it. Not verified, and not the fund's current assets. Source: U.S. Securities and Exchange Commission, Form D data sets.
Foundations that report holding this fund
| Foundation | State | Value reported | Basis | Tax year ended |
|---|---|---|---|---|
| Blue Water Foundation | MN | $403,784 | fair market value | Dec 31, 2024 |
1 private foundation listed this fund by name among the investments on its IRS Form 990-PF. The value is the year-end figure the foundation reported, exactly as filed (fair market value where given, otherwise book value); holdings may have changed since, and other investors in the fund are not listed. Matched by the fund's full name; not verified by AltMountain or by the fund. Source: Internal Revenue Service, Form 990 series e-file data.
Questions about Propel Bio Partners L.P.
What is the minimum investment for Propel Bio Partners L.P.?
Propel Bio Partners L.P.'s latest Form D, filed Mar 15, 2023, does not set a minimum investment. Managers can still require one in the offering documents.
Who can invest in Propel Bio Partners L.P.?
Propel Bio Partners L.P. is generally open only to accredited investors, and it may have no more than 100 beneficial owners because it relies on Section 3(c)(1). It uses Rule 506(b), which does not allow general advertising.
How much has Propel Bio Partners L.P. raised?
Propel Bio Partners L.P. reports $38,950,000 sold from 14 investors on its Form D filed Mar 15, 2023. This is cumulative sales since the offering began, not current assets or performance.
Where is Propel Bio Partners L.P. based?
Propel Bio Partners L.P. is based in Los Angeles, California.
When did Propel Bio Partners L.P. launch?
Propel Bio Partners L.P. reports its first sale in May 2022.
Size compared with every private equity fund
Raised more than 79% of the 1,741 private equity funds based in California, and more than 60% of all 8,931 that report sales.